Poor in vitro activity of ceftazidime/avibactam, ceftolozane/tazobactam, and meropenem/vaborbactam against carbapenem-resistant Pseudomonas aeruginosa in India: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2018-2021
Journal
The Journal of infection
Journal Volume
87
Journal Issue
1
Date Issued
2023-07
Author(s)
Lee, Yu-Lin
Type
letter